L-Amino acid oxidase (LOX) modulation of melphalan activity against intracranial glioma

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 3, 1996, Pages 179-186

  Moynihan, Kate ^a   Elion, Gertrude B ^a   Pegram, Charles ^a   Reist, Craig J ^a   Wellner, Daniel ^b   Bigner, Darell D ^a   Griffith, Owen W ^c   Friedman, Henry S ^a  

^a DUKE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Glioma; L Amino acid oxidase; Large neutral amino acids; Melphalan

Indexed keywords

AMINO ACID OXIDASE; ANTISERUM; MELPHALAN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLIOMA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

EID: 0031060432     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050557     Document Type: Article

References (24)

1. Bergel F, Stock JA (1953) Cytotoxic alpha amino acids and endopeptides. Br Emp Cancer Camp Annu Rep 31:6
2. Bullard DE, Schold SC Jr, Bigner SH, Bigner DD (1981) Growth and chemotherapeutic response in athymic mice of tumor arising from human glioma-derived cell line. J Neuropathol Exp Neurol 40:410
3. Cornford EM, Young D, Paxton JW, Finlay GJ, Wilson WR, Pardridge WM (1992) Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cancer Res 52:138
4. Friedman HS, Colvin OM, Ludeman SM, Schold SC Jr, Boyd VL, Mulhbaier LH, Bigner DD (1986) Experimental chemotherapy of human medulloblastoma with classical alkylators. Cancer Res 46:2827
5. Friedman HS, Schold SC Jr, Mahaley MS Jr, Colvin OM, Oakes WJ, Vick NA, Burger PC, Bigner SH, Borowitz M, Halperin EC, Djang W, Falletta JM, DeLong R, Garvin JH, DeVivo DC, Norris D, Golumbe B, Winter J, Bodziner RA, Sipahi H, Bigner DD (1989) Phase II treatment of medulloblastoma and pineoblastoma with melphalan:clinical therapy based on experimental models of human medulloblastoma. J Clin Oncol 7:904
6. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP (1973) In vitro cultivation of human tumors:establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417
7. Greig NH, Momma S, Sweeny DJ, Smith QR, Rapoport SI (1987) Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res 47:1571
8. Greig NH, Sweeny DJ, Rapoport SI (1988) Comparative brain and plasma pharacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Cancer Chemother Pharmacol 21:1
9. Groothius DR, Lippitz BE, Fekete I, Schlageter KE, Molnar P, Colvin OM, Roe CR, Bigner DD, Friedman HS (1992) The effect of an amino-acid lowering diet on the rate of melphalan entry into the brain and xenotransplanted glioma. Cancer Res 52:5590
10. Horowitz ME, Etcubanas E, Christenson ML, Houghton JA, George SL, Green AA, Houghton PJ (1988) Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development. J Clin Oncol 6:308
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265
12. Olendorf WH (1971) Brain uptake of amino acids, amines, and hexoses after arterial injection. Am J Physiol 221:1629
13. Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood brain barrier. J Neurochem 28:103
14. Pardridge WM (1983) Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 63:1481
15. Pardridge WM (1986) Blood-brain transport of nutrients Introduction. Fed Proc 45:2047
16. Pardridge WM (1987) Phenylalanine transport at the human blood-brain barrier. In: Kaufman S (ed) Amino acids in health and disease: new perspectives. Alan R. Liss, New York, p 43
17. Pardridge WM, Choi TB (1986) Neutral amino acid transport at the human blood-brain barrier. Fed Proc 45:2073
18. Pritchard J, McElwain TJ, Graham-Pole J (1982) High-dose melphalan with autologous marrow for the treatment of advanced neuroblastoma. J Cancer 45:86
19. Rich JN, Elion GB, Wellner D, Colvin OM, Groothius DR, Hilton JH, Schlageter KE, Bigner DD, Griffith OW, Friedman HS (1995) The effect of L-amino acid oxidase on activity of melphalan against an intracranial xenograft. Cancer Chemother Pharmacol 36:379
20. Smith JP, Rutledge F, Warton JT (1972) Chemotherapy of ovarian cancer. New approaches to treatment. Cancer 1:1565
21. Takada Y, Greig NH, Vistica DT, Rapoport SI, Smith QR (1991) Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother Pharmacol 29:89
22. Wellner D (1966) Evidence for conformational changes in L-amino acid oxidase associated with reversible inactivation. Biochemistry 5:1585
23. Wellner D, Meister A (1960) Crystalline L-amino acid oxidase of Crotalus adamanteus. J Biol Chem 235:2013
24. Wellner D, Old LJ, Beth E (1972) Effect of L-amino acid oxidase (LOX) injections on plasma amino acid concentrations. Fed Proc 31:921